This is the authors' abstract. We don't add key points for this paper.
Acute liver injury is closely linked to the pathophysiological cascade effect of iron dysregulation and oxidative stress caused by ferroptosis. Existing monotherapies using iron chelators or antioxidants fail to meet the need for bidirectional regulation and lack targeting and specificity. In this study, nanomedicine composed of piezoelectric materials and nanozyme (BTO@CeO 2 ) was developed for piezo-mediated dual-mode therapy of iron homeostasis regulation and free radical scavenging under localized ultrasound excitation: piezoelectric polarization reduced CeO 2 's energy barriers and enhanced its superoxide dismutase-like enzyme activity through electron injection and orbital hybridization for efficient reactive oxygen species (ROS) scavenging; BTO-generated holes reduced unstable iron pools by oxidizing divalent iron ions to achieve iron homeostasis; ultimately achieving efficient and high spatiotemporal precision in reversing ferroptosis. BTO@CeO 2 achieved antioxidant and iron metabolism reprogramming by regulating ferritinophagy, successfully alleviating drug-induced acute liver injury. This work demonstrates the great potential of piezoelectric-nanozyme synergistic precision treatment of metabolic diseases.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: